{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:39:59Z","timestamp":1759588799946,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T00:00:00Z","timestamp":1650326400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Detection of lymph node (LN) metastases in prostate cancer (PCa) is pivotal for accurate staging and determining treatment options. To date, the reference standard for nodal staging is histopathological examination of all harvested surgical specimens from extended pelvic LN dissections. However, this is a labor-intensive process, and small metastatic foci can be missed due to sampling effects. With current research expanding toward using radiolabeled prostate-specific membrane antigen ligands for image-guided surgery, new opportunities arise for image-guided pathological assessment of surgical specimens. Here, we illustrate how molecular imaging can complement histopathology and improve accurate detection of LN metastases.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004158","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T18:00:05Z","timestamp":1650391205000},"page":"559-561","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["How Image-Guided Pathology Can Improve the Detection of Lymph Node Metastases in Prostate Cancer"],"prefix":"10.1097","volume":"47","author":[{"given":"Melline G.M.","family":"Schilham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"K\u00fcsters-Vandevelde","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diederik M.","family":"Somford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rijpkema","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gotthardt","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","year":"2021","journal-title":"Eur Urol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2967\/jnumed.120.252114","article-title":"Safety, biodistribution, and radiation dosimetry of 18F-rhPSMA-7.3 in healthy adult volunteers","volume":"62","year":"2021","journal-title":"J Nucl Med"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-014-0063-1","article-title":"Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer","volume":"4","year":"2014","journal-title":"EJNMMI Res"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00428-013-1510-5","article-title":"Histological step sectioning of pelvic lymph nodes increases the number of identified lymph node metastases","volume":"464","year":"2014","journal-title":"Virchows Arch"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/modpathol.2010.160","article-title":"International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes","volume":"24","year":"2011","journal-title":"Mod Pathol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/jclinpath-2016-203643","article-title":"Lymph node staging in prostate cancer: perspective for the pathologist","volume":"69","year":"2016","journal-title":"J Clin Pathol"},{"journal-title":"J Nucl Med","article-title":"Epidermal growth factor receptor targeted fluorescence molecular imaging for postoperative lymph node assessment in patients with oral cancer","year":"2021","key":"bib7-20250621"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1200\/JCO.2005.05.4767","article-title":"Detection of occult lymph node metastases in locally advanced node-negative prostate cancer","volume":"24","year":"2006","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:01Z","timestamp":1750536061000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,19]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004158","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,4,19]]}}}